Sean Bo­hen just wrote the hand­book on how to make a quick for­tune in biotech

If you ask any­one in drug de­vel­op­ment about what mo­ti­vates them — or even if you don’t — you’re go­ing to get a reg­u­lar dou­ble-bar­reled blast about pa­tients and un­met med­ical needs if you’re cov­er­ing this in­dus­try. Less dis­cussed and just as im­por­tant dur­ing a heady IPO boom is a shot at the overnight for­tunes that are on of­fer in the mid­dle of a pan­dem­ic.

Sean Bo­hen’s team at Ole­ma just spelled it all out in an S-1 that can serve as a com­pact­ly writ­ten hand­book on the sub­ject — pro­vid­ed you know the back­ground.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE